Description
SS-31 50MG supplied by PureTy Peptides for qualified laboratory buyers. Modality: Injectable; presentation: 50MG.
Areas of research interest
- Targets Mitochondrial disfunction
- Improves energy output
- Reduces oxidative stress
- Protects against aging-related decline
Specifications
- Modality: Injectable
- Presentation: 50MG
- Purity target: ≥99% (batch-specific COA available on request)
For research use only. Not for human or animal use.
Reviews
There are no reviews yet.